This is associated with an increase in CCL20/LARC expression by CXCL1 [126], indicating some change in the expression of secretory factors during ovarian cancer development, in which CXCL1 is crucial at its beginning and CCL20/LARC at later stages. The gene discussed is CCL20; the disease is ovarian cancer.